Navigation Links
Saint Jude Retreats Announces Recent Creation of Non-12 Step Group on LinkedIn
Date:12/20/2013

Amsterdam, NY (PRWEB) December 20, 2013

The Saint Jude Retreats is proud to announce that on December 17, 2013 the Business Development Director, Susanne Herrmann, created a Non-12 step group on LinkedIn for professionals in the field and followers of the non-treatment movement.

Herrmann is looking forward to the opportunity to build a thriving network of people who are distancing themselves from addiction treatment and ideology, whether they are expressing professional or personal interest for alternatives to traditional substance use treatment. Saint Jude Retreats is an alternative to 12 step programs, based on research that shows that addiction is not an incurable, genetic disease, but a choice and can be overcome through a positive thought process, positive choice making and self-directed neuroplastic change.

The active involvement of Herrmann on LinkedIn recently lead to the building of an informal social network of professionals interested in alternatives to treatment and that provoked the idea to create a group that will be able to collaborate virtually. “I am very excited to create a non-12 step group on LinkedIn where like-minded professionals can create informative and interesting discussions as well as learn the latest research in substance use. Our intent is to hold the very first non-12 step conference in New York City next year and to invite professionals from the group to attend or participate in some way. We’d like to make it an annual national conference and eventually grow it into a world conference,” says Herrmann.

The Business Development Director, Susanne Herrmann, did not expand on the plans for a National Non-12 step conference but said that Baldwin Research Institute, the parent company of Saint Jude Retreats, is actively working on developing new strategies for a larger outreach and awareness that will be implemented by the end of next year.

To join the group visit: Saint Jude Retreats Non-12 Step LinkedIn Group.

The Saint Jude Retreats is a non-disease, non-treatment based drug and alcohol program implementing proprietary methodology called Cognitive Behavioral Education (CBE). The program is the only effective alternative to alcohol rehab and drug treatment centers and is currently 85% more effective than treatment. The program is endorsed by internationally acclaimed professionals and addiction research authors such as Dr. Joy Browne and the late Joseph Vacca, PhD, among others.

Saint Jude Retreats Facebook Page
Saint Jude Retreats Google + Page
Saint Jude Retreats Twitter Page

Read the full story at http://www.prweb.com/releases/2013/12/prweb11439280.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Saint Jude Retreats Announces Recent Representation at NACDL's 6th Annual Drug Defenses Conference
2. Saint Jude Retreats Announces Chairman Mark Scheeren’s Recent Radio Interview
3. Saint Luke’s Hospital to Offer New Comprehensive Lung Cancer Screening Program
4. Saint Jude Retreats' Business Development Director Attends Long Island EAPA Chapter Meeting
5. Saint Jude Retreats' Business Development Director Attends NYC EAPA Chapter Meeting
6. Saint Joseph’s University Partners with Reading Area Community College
7. Saint Xavier University Names New Online Msn Program Director
8. The Life Support Technologies Group Installs Two Additional Hyperbaric Chambers at Saint Francis Hospital and Medical Center, Hartford, CT
9. Austin Mahone Tickets in Fresno, Miami Beach, Orlando, Saint Petersburg, Atlanta, Silver Spring, New York, Philadelphia, Boston, Pittsburgh & Royal Oak Onsale August 2nd
10. University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials
11. Sainthood Herbs’ New, Globally Sourced Supplements Offer Health Solutions Without The Guesswork
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known for myriad ... a show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a ... plummeted in large part due to early detection. Like any other disease, treatments have ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® was ... Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony and ... Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ingenuity, ...
(Date:12/4/2016)... ... December 04, 2016 , ... Patients who wish ... take advantage of a cosmetic procedure known as Carbon Dioxide (C02) Fractional ... appearance of age spots, fine lines, uneven coloration, wrinkles, scarring, skin laxity ...
(Date:12/4/2016)... ... ... Responsible dental care hinges on regular brushing of the teeth. However, just brushing ... inspired an inventor from Las Vegas, Nev., to design the BRUSH PROPER. , ... bad techniques of brushing the teeth in order to prevent cavities," he said. "Children ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and ... will speak at the American Conference Institute’s 21st Drug & Medical Device Litigation ... Lead Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... OSWEGO, Ore. , Dec. 5, 2016   ... the BioInsight clinical study. The study evaluates the safety ... insertion procedure in an office setting. BioMonitor ... ® technology that is placed underneath a patient,s ... fibrillation and syncope (fainting). Atrial fibrillation is a leading ...
(Date:12/5/2016)... PITTSBURGH , Dec. 5, 2016  Wellbridge Health and ... innovative digital health solutions to Medicare and Medicaid plan members ... effort targeted at the unique needs of this group of ... on social work philosophies to provide insight into members, daily ... , ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Daiichi ... preliminary safety and efficacy data from a phase ... MDM2 inhibitor, suggesting that DS-3032 may be a ... myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). ... the phase 1 study of DS-3032 were presented in ...
Breaking Medicine Technology: